S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Modern Day Options Trading For Beginners! (Ad)pixel
Germany, EU reach agreement in combustion engine row
Intel co-founder, philanthropist Gordon Moore dies at 94
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Biden's moves on Alaska drilling, TikTok test young voters
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Ruling halts oil exports from Iraq's Kurdish area via Turkey
Finnish leadership condemns attack on veteran lawmaker
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Modern Day Options Trading For Beginners! (Ad)pixel
Germany, EU reach agreement in combustion engine row
Intel co-founder, philanthropist Gordon Moore dies at 94
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Biden's moves on Alaska drilling, TikTok test young voters
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Ruling halts oil exports from Iraq's Kurdish area via Turkey
Finnish leadership condemns attack on veteran lawmaker
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Modern Day Options Trading For Beginners! (Ad)pixel
Germany, EU reach agreement in combustion engine row
Intel co-founder, philanthropist Gordon Moore dies at 94
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Biden's moves on Alaska drilling, TikTok test young voters
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Ruling halts oil exports from Iraq's Kurdish area via Turkey
Finnish leadership condemns attack on veteran lawmaker
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Modern Day Options Trading For Beginners! (Ad)pixel
Germany, EU reach agreement in combustion engine row
Intel co-founder, philanthropist Gordon Moore dies at 94
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Judge rules online archive's book service violated copyright
Biden's moves on Alaska drilling, TikTok test young voters
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Ruling halts oil exports from Iraq's Kurdish area via Turkey
Finnish leadership condemns attack on veteran lawmaker
OTCMKTS:MYCOF

Mydecine Innovations Group - MYCOF Stock Forecast, Price & News

$0.38
-0.03 (-7.32%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.36
$0.44
50-Day Range
$0.36
$0.47
52-Week Range
$0.05
$5.00
Volume
62,681 shs
Average Volume
9,665 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MYCOF stock logo

About Mydecine Innovations Group (OTCMKTS:MYCOF) Stock

Mydecine Innovations Group, Inc. operates as a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions. It encompasses three companies: Mindleap Health, Mydecine Health Sciences, and NeuroPharm Inc. The Mindleap Health is an advanced digital health platform that helps people connect with mental health specialists who can empower them to thrive and develop habits for a healthy mind. The Mydecine Health Sciences is a vertically integrated company developing novel fungtional mushroom products and psychedelic medicines for healthy and vulnerable populations. The NeuroPharm is developing a unique and proprietary set of pharmaceutical and natural health products addressing mental wellness in vulnerable populations. The company was founded by Parente Carman on September 27, 2013 and is headquartered in Vancouver, Canada.

Receive MYCOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mydecine Innovations Group and its competitors with MarketBeat's FREE daily newsletter.

MYCOF Stock News Headlines

Mydecine Announces Debt Settlements
KAVL Kaival Brands Innovations Group, Inc.
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
Mydecine Innovations Group GAAP EPS of -C$0.35
MYDECINE INNOVATIONS GROUP FILES PROSPECTUS...
MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT
See More Headlines
Receive MYCOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mydecine Innovations Group and its competitors with MarketBeat's FREE daily newsletter.

MYCOF Company Calendar

Last Earnings
11/16/2021
Today
3/25/2023

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:MYCOF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • David Joshua Bartch
    Chairman, President & Chief Executive Officer
  • Damon Michaels
    Chief Operating Officer
  • John Charles Ross
    Chief Financial Officer
  • Robert Roscow
    Director & Chief Science Officer
  • Rakesh Jetly
    Chief Medical Officer













MYCOF Stock - Frequently Asked Questions

How have MYCOF shares performed in 2023?

Mydecine Innovations Group's stock was trading at $0.43 at the beginning of 2023. Since then, MYCOF shares have decreased by 11.6% and is now trading at $0.38.
View the best growth stocks for 2023 here
.

Are investors shorting Mydecine Innovations Group?

Mydecine Innovations Group saw a decline in short interest in the month of February. As of February 28th, there was short interest totaling 300 shares, a decline of 50.0% from the February 13th total of 600 shares. Based on an average trading volume of 25,000 shares, the days-to-cover ratio is presently 0.0 days.
View Mydecine Innovations Group's Short Interest
.

How were Mydecine Innovations Group's earnings last quarter?

Mydecine Innovations Group Inc. (OTCMKTS:MYCOF) issued its quarterly earnings results on Tuesday, November, 16th. The company reported ($1.00) EPS for the quarter, missing analysts' consensus estimates of ($0.50) by $0.50.

When did Mydecine Innovations Group's stock split?

Mydecine Innovations Group shares reverse split before market open on Thursday, April 21st 2022. The 1-50 reverse split was announced on Thursday, April 21st 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, April 21st 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What is Mydecine Innovations Group's stock symbol?

Mydecine Innovations Group trades on the OTCMKTS under the ticker symbol "MYCOF."

How do I buy shares of Mydecine Innovations Group?

Shares of MYCOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Mydecine Innovations Group's stock price today?

One share of MYCOF stock can currently be purchased for approximately $0.38.

How can I contact Mydecine Innovations Group?

Mydecine Innovations Group's mailing address is 789 West Pender Street, Vancouver, BC V6C. The official website for the company is www.mydecine.com. The company can be reached via phone at (813) 871-3936.

This page (OTCMKTS:MYCOF) was last updated on 3/26/2023 by MarketBeat.com Staff